Brian I Rini (Brian Rini)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Chronic Myeloid Leukemia

Placebo Controlled

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery (2024)
Kathryn E Beckermann, Aviva G Asnis-Alibozek, Michael B Atkins, Bernard Escudier, Thomas E Hutson, Vijay Kasturi, David F McDermott, Sumanta K Pal, Camillo Porta, Brian I Rini, Elena Verzoni
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial. The oncologist 29 (3) (2024)
Kathryn E Beckermann, Aviva G Asnis-Alibozek, Michael B Atkins, Bernard Escudier, Thomas E Hutson, Vijay Kasturi, David F McDermott, Sumanta K Pal, Camillo Porta, Brian I Rini, Elena Verzoni
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial. The oncologist (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery 14 (3) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kathryn E Beckermann, Aviva G Asnis-Alibozek, Michael B Atkins, Bernard Escudier, Thomas E Hutson, Vijay Kasturi, David F McDermott, Sumanta K Pal, Camillo Porta, Brian I Rini, Elena Verzoni
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial. The oncologist 29 (3) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Brian I Rini, James Brugarolas, Michael B Atkins
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma. Journal for immunotherapy of cancer 11 (3) (2023)
Brian I Rini, James Brugarolas, Michael B Atkins
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma. Journal for immunotherapy of cancer 11 (3) (2023)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Javid J Moslehi, Subramanian Hariharan
Reply to S. Tan et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Landon C Brown, Kunal Desai, Wei Wei, Emily N Kinsey, Chester Kao, Daniel J George, Brian I Rini, Moshe C Ornstein, Tian Zhang
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal for immunotherapy of cancer 9 (9) (2022)
Brian I Rini, Javid J Moslehi, Marc Bonaca, Manuela Schmidinger, Laurence Albiges, Toni K Choueiri, Robert J Motzer, Michael B Atkins, John B A G Haanen, Mariangela Mariani, Jing Wang, Subramanian Hariharan, James M G Larkin
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Erin M Wilfong, Christine M Lovly, Erin A Gillaspie, Li-Ching Huang, Yu Shyr, Jonathan Dale Casey, Brian I Rini, Matthew W Semler
Severity of illness scores at presentation predict ICU admission and mortality in COVID-19. Journal of emergency and critical care medicine (Hong Kong, China) 5 (2021)